[Femoral venous catheterization. Does it really need to be avoided?]
Related Experiment Video
Updated: Jun 18, 2026

Femoral Arterial and Venous Catheterization for Blood Sampling, Drug Administration and Conscious Blood Pressure and Heart Rate Measurements
Published on: January 24, 2012
1Unidad de Cuidados Intensivos, Hospital Universitario de Canarias, La Laguna, Tenerife, España. lorentemartin@msn.com
Insights
Current guidelines recommend subclavian vein access to prevent central venous catheter bloodstream infections (CVCBSI), but this may increase mechanical complications. Antimicrobial-impregnated catheters could be an alternative for femoral venous access to reduce CVCBSI rates.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Medical Guidelines
Background:
- Established guidelines from CDC, SEMICYUC/SEIMC, and SHEA/IDSA recommend specific central venous catheter (CVC) insertion sites to prevent bloodstream infections (CVCBSI).
- These guidelines advocate for subclavian vein use while discouraging femoral vein access.
- Consideration is also given to antiseptic- or antimicrobial-impregnated CVCs in high-risk settings for CVCBSI prevention.
Purpose of the Study:
- To evaluate the potential trade-offs of current CVCBSI prevention guidelines, specifically the increased risk of mechanical complications with subclavian vein preference.
- To explore the efficacy of antimicrobial-impregnated CVCs as a strategy to prevent CVCBSI when femoral venous access is utilized.
Main Methods:
- Review and analysis of existing guidelines on central venous catheter insertion practices and infection prevention.
- Assessment of the potential association between preferred insertion sites (subclavian vs. femoral) and mechanical complication rates.
- Evaluation of the role and effectiveness of antimicrobial-impregnated CVCs in preventing CVCBSI, particularly with alternative access sites.
Main Results:
- Increased utilization of the subclavian vein may lead to a reduction in CVCBSI.
- Conversely, a higher incidence of mechanical complications such as pneumothorax and hemothorax may occur with increased subclavian vein use.
- Antimicrobial-impregnated CVCs present a potential alternative for preventing CVCBSI when femoral venous access is necessary.
Conclusions:
- The current emphasis on subclavian vein access for CVC insertion may inadvertently increase mechanical complication risks.
- Antimicrobial-impregnated CVCs offer a promising strategy to mitigate CVCBSI risks, especially when femoral access is chosen.
- Further research is warranted to balance the risks and benefits of different CVC insertion sites and catheter types in infection prevention.
Abstract:
The guidelines to prevent central venous catheter related bloodstream infections (CVCBSI) of the Centers for Disease Control and Prevention (CDC) of 2002, Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias/ Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEMICYUC/SEIMC) of 2004, and the recently published guidelines of the Society for Healthcare Epidemiology of America/Infectious Diseases Society of America (SHEA(IDSA) of 2008 have recommended using the subclavian vein and avoiding the use of the femoral vein. They also recommend considering the use of antiseptic- or antimicrobial-impregnated CVCs for hospital units or groups of patients with a high incidence of CVCBSI. When implementing these guidelines, two questions could be asked: 1) Could the abuse of the subclavian vein and avoiding the use of the femoral vein imply a decrease in the incidence of CVCBSI, but an increase in the rate of mechanical complications as pneumothorax and/or hemothorax? 2) Couldn't antimicrobial-impregnated CVCs be used to prevent CVCBSI when the femoral venous access is used?
Related Concept Videos
Cardiac Catheterization IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Hemodialysis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Cardiac Catheterization III: Left Heart Catheterization

